Bayer board says Monsanto acquisition was done diligently

  • 📰 BDliveSA
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 63%

Health Health Headlines News

Bayer shares dropped when a US jury found Bayer liable because its Monsanto unit did not warn of Roundup’s alleged cancer risks — risks others deny

Bayer has acquired Monsanto, maker of the controversial weedkiller Roundup. Picture: BLOOMBERG/DANIEL ACKER

In documents posted on the company’s website on Monday, the non-executive supervisory board said an expert opinion it commissioned from law firm Linklaters found that Bayer’s management had complied with their duties when acquiring Monsanto for $63bn last year. Bayer shares have lost more than 35% of their value, equivalent to about €33bn in market capitalisation, since August, when a US jury found Bayer liable because its Monsanto unit did not warn of Roundup’s alleged cancer risks. It suffered a similar courtroom defeat last month.

CEO Werner Baumann, who broke cover on his pursuit of Monsanto within weeks of taking the top job in 2016, has said in newspaper interviews that he enjoys the backing of the supervisory board. The supervisory board in Germany’s two-tier corporate board system has to sign off on larger transactions and Bayer’s non-executive chair Werner Wenning backed the Monsanto deal throughout, according to sources familiar with the matter.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in HEALTH

Health Health Latest News, Health Health Headlines